Could an MUC1-Targeted Vaccine Benefit Colorectal Cancer Patients With Liver Mets?
Researchers tested an antigen-specific cancer vaccine known as tecemotide vs placebo in patients with colorectal cancer and liver metastases to see if outcomes would be improved.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Dave Levitan Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Colorectal Cancer | Liver | Urology & Nephrology | Vaccines